Cardiol Therapeutics Net Income From Continuing Ops Over Time
| CRDL Stock | USD 1.44 0.04 2.70% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Cardiol Therapeutics Performance and Cardiol Therapeutics Correlation. Cardiol |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardiol Therapeutics. If investors know Cardiol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardiol Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.39) | Return On Assets (0.54) | Return On Equity (1.08) |
The market value of Cardiol Therapeutics is measured differently than its book value, which is the value of Cardiol that is recorded on the company's balance sheet. Investors also form their own opinion of Cardiol Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Cardiol Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardiol Therapeutics' market value can be influenced by many factors that don't directly affect Cardiol Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardiol Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardiol Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardiol Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Income From Continuing Ops Analysis
Compare Cardiol Therapeutics and related stocks such as Flora Growth Corp, ABVC Biopharma, and Indaptus Therapeutics Net Income From Continuing Ops Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FLGC | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (21.4 M) | (52.6 M) | (56.2 M) | (59 M) |
| ABVC | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (4.5 M) | (4.2 M) | (4.1 M) | (3.9 M) | (10.6 M) | (12 M) | (16.3 M) | (10.9 M) | (11.5 M) |
| INDP | (3.6 M) | (3.6 M) | (3.6 M) | (3.6 M) | (3.6 M) | (3.6 M) | (3.6 M) | (3.6 M) | (3.6 M) | (3.6 M) | (3.6 M) | (7.7 M) | (14.3 M) | (15.1 M) | (15.8 M) |
| HCWB | (7.3 M) | (7.3 M) | (7.3 M) | (7.3 M) | (7.3 M) | (7.3 M) | (7.3 M) | (7.3 M) | (7.3 M) | (7.3 M) | (5.8 M) | (12.9 M) | (15.2 M) | (19.7 M) | (18.7 M) |
| PRFX | (828 K) | (828 K) | (828 K) | (828 K) | (828 K) | (828 K) | (828 K) | (828 K) | (828 K) | (1.3 M) | (4.1 M) | (7.2 M) | (8.8 M) | (9.3 M) | (8.9 M) |
Cardiol Therapeutics and related stocks such as Flora Growth Corp, ABVC Biopharma, and Indaptus Therapeutics Net Income From Continuing Ops description
My Equities
My Current Equities and Potential Positions
| Cardiol Therapeutics Class | CRDL |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Ontario; Canada |
| Exchange | NASDAQ Exchange |
USD 1.44
Check out Cardiol Therapeutics Performance and Cardiol Therapeutics Correlation. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Cardiol Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.